Manchester’s leukaemia achievements celebrated in top research report
Research conducted by
The University of Manchester, Central Manchester NHS Hospital NHS
Foundation Trust and The Christie NHS Foundation Trust has been
featured in the Medical Schools Council's Health of
the Nation: The impact of UK medical schools' researchreport,
which highlights the very best medical research happening
across the UK and its impact.
The publication put the spotlight on Manchester's work on
improving outcomes for children with Acute Lymphoblastic Leukaemia
(ALL) internationally, with almost nine out of 10 new patients
diagnosed with paediatric ALL in the UK now expected to make a full
recovery - one of the best survival rates in the world - following
research conducted within the city.
However, Manchester's research has also had a significant impact
across the world, with the outcome for children with relapsed ALL
up 10% in the UK, Netherlands, Australia and New Zealand, and
relapse protocol based on the research underpinning European and
North American strategies for the management of the disease.
The report specifically mentions work conducted by The
University of Manchester Emeritus Professor Tim Eden between 1993
and 2003, which led to different medications being used for the
disease. It also details the work of Professor Vaskar Saha's on
treating relapsed patients, including the first international
trial on relapsed ALL.
Read the Health of the Nation report
Find out more about Manchester's research into ALL in the video
below, created by Haelo